AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19
AstraZeneca’s experimental COVID-19 antibody-drug cocktail succeeded in reducing severe disease or death in non-hospitalised patients in a late-stage study.
The pharma company announced the results on Monday, marking a boost in its…